Ulrik Niels Lassen

Ulrik Niels Lassen

Clinical Professor

Member of:

  • Clinical Oncology


Publication year:
All
1 - 10 out of 159Page size: 10
  1. 2023
  2. Published

    Characteristics of de novo cancer in liver transplant recipients

    Riis, T. H., Møller, D. L., Høgh, J., Knudsen, A. D., Rostved, A. A., Akdag, D., Kirkby, N., Lassen, Ulrik Niels, Rasmussen, A., Hillingsø, Jens Georg & Pommergaard, Hans-Christian L, 2023, In: APMIS. 131, 4, p. 135-141 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial

    Subbiah, V., Kreitman, R. J., Wainberg, Z. A., Gazzah, A., Lassen, U., Stein, A., Wen, P. Y., Dietrich, S., de Jonge, M. J. A., Blay, J-Y., Italiano, A., Yonemori, K., Cho, D. C., de Vos, F. Y. F. L., Moreau, P., Fernandez, E. E., Schellens, J. H. M., Zielinski, C. C., Redhu, S., Boran, A. & 3 others, Passos, V. Q., Ilankumaran, P. & Bang, Y., 2023, In: Nature Medicine. 29, 5, p. 1103-1112 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Impact of multimorbidity and polypharmacy on mortality after cancer: a nationwide registry-based cohort study in Denmark 2005–2017

    Thomsen, M. K., Løppenthin, K. B., Bidstrup, P. E., Andersen, E. W., Dalton, Susanne Oksbjerg, Petersen, L. N., Pappot, Helle, Mortensen, C. E., Christensen, Mikkel Bring, Frølich, Anne, Lassen, Ulrik Niels & Johansen, Christoffer, 2023, In: Acta Oncologica. 62, 12, p. 1653-1660 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Neoepitope load, T cell signatures and PD-L2 as combined biomarker strategy for response to checkpoint inhibition immunotherapy

    Borch, A., Bjerregaard, A. M., Araujo Barbosa de Lima, V., Østrup, O., Yde, C. W., Eklund, A. C., Mau-Sørensen, M., Barra, C., Svane, Inge Marie, Nielsen, Finn Cilius, Funt, S. A., Lassen, Ulrik Niels & Hadrup, S. R., 2023, In: Frontiers in Genetics. 14, 13 p., 1058605.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    New pathogenic germline variants identified in mesothelioma

    Belcaid, L., Bertelsen, B., Wadt, Karin Anna Wallentin, Tuxen, I., Spanggaard, I., Højgaard, M., Sørensen, Jens Benn, Ravn, J., Lassen, Ulrik Niels, Nielsen, Finn Cilius, Rohrberg, K. & Westmose Yde, C., 2023, In: Lung Cancer. 179, 8 p., 107172.

    Research output: Contribution to journal › Review › Research › peer-review

  7. Published

    Precision cancer medicine: Concepts, current practice, and future developments

    Edsjö, A., Holmquist, L., Geoerger, B., Nowak, F., Gomon, G., Alix-Panabières, C., Ploeger, C., Lassen, Ulrik Niels, Le Tourneau, C., Lehtiö, J., Ott, P. A., von Deimling, A., Fröhling, S., Voest, E., Klauschen, F., Dienstmann, R., Alshibany, A., Siu, L. L. & Stenzinger, A., 2023, In: Journal of Internal Medicine. 294, 4, p. 455-481 27 p.

    Research output: Contribution to journal › Review › Research › peer-review

  8. Published

    ProTarget: a Danish Nationwide Clinical Trial on Targeted Cancer Treatment based on genomic profiling – a national, phase 2, prospective, multi-drug, non-randomized, open-label basket trial

    Kringelbach, T., Højgaard, M., Rohrberg, K., Spanggaard, I., Laursen, Britt Elmedal, Ladekarl, M., Haslund, C. A., Harsløf, L., Belcaid, L., Gehl, Julie, Søndergaard, L., Eefsen, R. L., Hansen, K. H., Kodahl, A. R., Jensen, L. H., Holt, M. I., Oellegaard, T. H., Yde, C. W., Ahlborn, L. B. & Lassen, Ulrik Niels, 2023, In: BMC Cancer. 23, 1, 12 p., 182.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Putting data to work for precision medicine

    Bjerrum, A. & Lassen, Ulrik Niels, 2023, In: Cell Reports Medicine. 4, 7, 3 p., 101090.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  10. Published

    Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial

    Omuro, A., Brandes, A. A., Carpentier, A. F., Idbaih, A., Reardon, D. A., Cloughesy, T., Sumrall, A., Baehring, J., van den Bent, M., Bähr, O., Lombardi, G., Mulholland, P., Tabatabai, G., Lassen, U., Sepulveda, J. M., Khasraw, M., Vauleon, E., Muragaki, Y., Di Giacomo, A. M., Butowski, N. & 9 others, Roth, P., Qian, X., Fu, A. Z., Liu, Y., Potter, V., Chalamandaris, A. G., Tatsuoka, K., Lim, M. & Weller, M., 2023, In: Neuro-Oncology. 25, 1, p. 123-134 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Supporting Biomarker-Driven Therapies in Oncology: A Genomic Testing Cost Calculator

    Stenzinger, A., Cuffel, B., Paracha, N., Vail, E., Garcia-Foncillas, J., Goodman, C., Lassen, Ulrik Niels, Vassal, G. & Sullivan, S. D., 2023, In: Oncologist. 28, 5, p. e242-e253

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...16 Next

ID: 4952653